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The goal of this study was to test the feasibility of BALB/c mice as an experimental model in the study of dengue disease. BALB/c mice
were intraperitoneal infected with DENV-2 obtained from a human patient. Histopathological analysis of infected animals revealed liver
injury with viral antigens detection. In initial stages, the most prominent lesions were vacuolization and diffuse steatosis in hepatocytes.
Serum levels of ALT and AST increased progressively, reaching the highest values 7 days p.i. and decreasing at the 14th day. Since levels of
circulating virus were very low, viremia was analyzed in C6/36 cells. Virus presence was detected by ultrastructural analysis, confirmed by
RT-PCR assays. Period of viremia was analyzed by flow cytometry with cells incubated with mouse-infected sera collected in different days,
revealing peak virus levels at the 7th day p.i. All such data correlate to the development of the disease described in humans.
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Dengue is an acute disease caused by the infection of
dengue virus (DENV), which consists of four distinct
antigenic types (DENV-1 to -4). The disease presents a
wide range of clinical symptoms, including a mild self-
limiting acute febrile illness (DENV fever) and hemorrhagic
fever and/or shock syndrome (DHF/DSS) (Halstead, 1989).
The clinical features of DHF include plasma leakage, a
tendency to bleed, and liver involvement (Rothman and
Ennis, 1999), which can progress to DSS and death
(Henchal and Putnak, 1990). Although the liver is not a
major target organ, the involvement of the liver in the
pathogenesis of dengue virus infection, in particular con-
cerning the development of DHS, was demonstrated by the0042-6822/$ - see front matter D 2005 Published by Elsevier Inc.
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E-mail address: marciano@ioc.fiocruz.br (M.V. Paes).abnormal liver function, tissular injury, presence of viral
antigens, and RNA in human liver tissue (Bhamarapravati
and Halstead, 1964; Bhamarapravati et al., 1967; Burke,
1968; Kalayanarooj et al., 1997; Kuo et al., 1992; Miagos-
tovich et al., 1997; Nguyen et al., 1997; Rosen et al., 1989,
1999; Wang et al., 1990).
In general, most experimental studies dealt with suckling
or young mice inoculated by the intracerebral route of a
mouse-adapted DENV-2 (Nath et al., 1983; Raut et al.,
1996). Animal responses to virus infection (clinical signs
and/or degree of injury) varies according to mice strain,
although these experimental models normally show that
mice are susceptible for DENV infection. The full DHF/
DSS manifestations, however, do not seem to occur in
standard laboratory mice.
Some studies are based on other inoculation routes, such
as intraperitoneal and intravenous, which resembles more to
the natural infection in human population. Huang et al.
(2000a, 2000b) showed that A/J mice inoculated intra-05) 236 – 246
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thrombocytopenia and anti-platelet antibodies. Such alter-
ations were remarkable reduced when BALB/c or B6 mice
were used (Huang et al., 2000a, 2000b). In nude mice,
petechial and gastrointestinal hemorrhages have been
observed (Raut et al., 1996). In the model of infection
developed in SCID mice submitted to the transplantation of
human hepatocarcinoma cell line (HepG2) foci of tissular
hemorrhagy, hemoconcentration and fluid extravasation,
thrombocytopenia, and prolonged partial thromboplastin
time were achieved (An et al., 1999). This model takes
advantage of the fact that HepG2 cells, a human hepatoma
cell line, which conserved numerous characteristics of
differentiated hepatocytes (Knowles et al., 1984), is
permissive for DENV infection and replication. HepG2
cells transplanted into SCID mice are able to restock liver,
and after viruses inoculation became the major target for
their replication. Infected cells die by an apoptotic mech-
anism as a direct consequence of the viral infection
(Marinneau et al., 1998). Moreover, these animals devel-
oped a hind-leg paralysis, liver injury, and renal dysfunc-
tion. Viremia in this model peaked at 8-day post-infection
(p.i.) but viruses were already seen in 60% of mice at day 5.
Viruses were detected in the hepatic tissue, brain, and blood
(An et al., 1999).
The present study has been undertaken to characterize a
mouse model of DENV-2 infection by intraperitoneal
inoculation of a non-adapted virus isolated from a human
patient. BALB/c mice developed an apparently mild
infection, but with liver injury characterized by histopatho-
logical aspects and biochemical tests. Viral antigens were
detected in focal areas of the damaged liver, confirming the
presence DENV-2 in such tissue. Viremia was analyzed by
flow cytometry with C6/36 cells incubated with mouse-
infected sera collected in different times, which revealed
peak virus levels at the 7th day p.i. in most animals. All such
data correlate to what is observed in the human disease and
therefore demonstrate that BALB/c mice strain is a
susceptible animal to DENV-2 and can be used as an
experimental model for the study of the pathogenesis of
dengue disease.Results
Mice infection
All mice inoculated with DENV-2 survived to the
infection and did not present clinical signs, although some
tissue pathological alterations could be detected. Liver of
control mice, inoculated only with culture medium, did not
exhibit any modification in their structure (Fig. 1a).
However, hepatic injury was seen in all DENV-2-infected
mice beginning from the 2nd until the 17th day p.i. (Figs.
1b–j). At the 2nd day p.i., hepatic plates maintained its
architecture and were generally constituted by mono-nucleated hepatocytes, although some of them were
binucleated. Some hepatocytes were slightly enlarged due
to vacuolization while others were diminished. Hepatocyte
vacuolization was observed all over the hepatic acini, but
was more prominent in the zone II of the liver acini where
cells were sparse. Slight variation in hepatocyte size could
be observed (midzonal, Fig. 1b). At the 3rd day p.i.,
diffuse steatosis were noted in hepatocytes around the
central vein area, mainly in sinusoidal side. Numerous
hyperplastic Kupffer cells were detected in sinusoids
capillary (Fig. 1c) and an increase of monocytes cells
was observed in sinusoids (Fig. 1d). At the 7th day p.i., an
intense area of edema was evident around the hepatocytes
nucleus, causing a progressive increase of necrosis area in
focal parenchyma. Sinusoid capillaries presented several
monocytes and lymphocytes (Fig. 1e). Diffuse necrose of
hepatocytes was also observed surrounding portal areas
with increased monocyte infiltration (Fig. 1f). At the 13th
day p.i., hepatocytes exhibited changes in their nuclear
content and lipid-like nuclear inclusions were occasionally
seen in vacuolated cells (Fig. 1g). Rare isolated or grouped
inflammatory cells (mononuclear cells) were focally seen
inside sinusoids at the 13th day p.i. Inflammation in
hepatic lobuli was characterized by the presence of
polymorphonuclear cells surrounding tumefacted hepato-
cytes with an intense cytoplasmic clarification (Fig. 1h). At
the 17th day p.i., apoptotic cells were seen at the
sinusoidal space as well as necrotic hepatocytes (Fig. 1i).
Although at this time point hepatocytes seemed to be
regenerated, focal rarefaction of sinusoidal cells and
sinusoidal disappearance were occasionally seen at the
17th day p.i. (Fig. 1j).
The semiquantitative analysis demonstrated that in
general at the 2nd day p.i., hepatocytes did not change
their diameter in relation to control mice (P > 0.05).
However, at the 13th day p.i., their diameter was
significantly increased (P < 0.05) (Fig. 2a). Sinusoidal
capillaries had a diminished diameter (P < 0.05) at the 2nd
day p.i. and became significantly enlarged later on (P <
0.05) (Fig. 2b). Analysis of sinusoidal cells revealed a
significantly decrease of the number such cells in all time
points (P < 0.05) (Fig. 2c).
Detection of viral antigen in the liver of infected mice
In order to confirm the presence of DENV-2 in liver
tissue, immunohistochemistry assays were performed using
a monkey polyclonal anti-DENV-2 antibody. At the 2nd day
p.i., viral antigens were detected in focal hepatocytes (Fig.
3c) and in the capillar endothelium of the central lobular
vein (Fig. 3d). The antigens were also detected in the
hepatocytes around the portal space (Fig. 3e). At the 13th
day p.i., virus antigens were also detected in focal zones
(Fig. 3g), although in a large extension as compared to the
2nd day p.i. Antigens were observed in plates of hepato-
cytes, in the same areas that exhibiting hepatic injury (Fig.
Fig. 1. Histological analysis of liver sections of control and DENV-2-infected mice, HE staining. (a) Liver section of a mouse inoculated with L-15 medium,
presenting hepatocytes, sinusoid capillars, and a central vein without alterations (scale bar = 30 Am); (b) liver of a mouse at the 2nd day p.i., showing
vacuolization (V) of hepatocytes and dilatation of sinusoid capillars around the central vein (scale bar = 20 Am); (c and d) liver of a mouse at the 3rd day p.i.
with diffuse steatosis at the sinusoidal side of hepatocytes and increase of the number of Kupffer cells (KC), observed around the central vein (c), and
microvesicular steatosis noted in the portal space and monocyte cells (MO) observed inside the sinusoids (d) (scale bars = 30 Am); (e and f) liver of a mouse at
the 7th day p.i. with necrosis of hepatocytes and tissue edema (E) and an increase of the number of monocytes (MO) and lymphocytes (LY) inside the sinusoid
capillaries (e), and hepatocyte necrosis (asterisk) with the presence of monocytes (MO) observed in portal areas (f) (scale bars = 30 Am); (g and h) liver section
of a mouse at the 13th day p.i. in which lipid-like nuclear inclusions may be observed in vacuolated (V) and tumefacted (asterisk) hepatocytes (scale bar = 8 Am
and 15 Am in panels g and h, respectively); (i and j) liver section of a mouse at the 17th day p.i. with apoptotic cells (Apc) occurring inside the sinusoidal
capillar space (i) and the disappearance of sinusoidal cells (SC) (j) (scale bars = 6 Am).
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Fig. 2. Semiquantitative analysis of hepatocyte (a), sinusoidal capillars (b),
and sinusoidal cells (c). (a) Hepatocytes in liver injury did not change their
diameters in relation to control mice ( P > 0.05), at the 2nd day p.i., while
their diameters were significantly increased ( P < 0.05) at the 13th day p.i.;
(b) sinusoidal capillar had a diminished diameter ( P < 0.05) at the 2nd day
p.i. and became enlarged significantly ( P < 0.05) in late infection; (c) the
number of sinusoidal cells diminished at the 2nd day p.i. and increase in
late infection ( P < 0.05).
M.V. Paes et al. / Virology 338 (2005) 236–246 2393g). As expected, negative control, constituted of liver of
non-infected mice reacting with anti-DENV-2 antibodies,
did not present any virus antigen (Fig. 3a). Furthermore,
livers of infected mice at the 2nd and 13th days p.i. also didnot present any reaction with the anti-human IgG conjugate
(Figs. 3b and f, respectively).
Transaminase level quantifications in serum samples of
DENV-2-infected mice
In order to investigate whether the hepatic injury detected
in infected mice correlates to alterations in transaminase
levels, semiquantitative analyses of alanine aminotransfer-
ase (ALT) and aspartate aminotransferase (AST) were
performed. In general, at the 7th and 14th days p.i., levels
of ALT and AST increased in most of the tested serum
samples as compared to control sera (Fig. 4). Apparently,
both transaminases presented peak level at the 7th day p.i.
The statistical analysis of the data, however, showed no
significance with the P = 0.051 at the 7th day p.i. The lack
of significance was probably due to a considerable inter-
individual variation.
Detection of DENV-2 in the C6/36 cell line inoculated with
sera from infected BALB/c mice
Since levels of circulating virus in infected mice were
very low (data not shown), for further analysis, C6/36 cells
were used in order to amplify the amount of DENV-2
particles obtained from serum samples collected from these
animals. Cells inoculated with mouse sera from the 2nd and
the 11th days p.i., examined 15 days after incubation,
presented viral particles inside the cisternae of the rough
endoplasmic reticulum (Figs. 5c and d, respectively).
Vacuolization was also observed in these cells, similar to
those detected in positive control cells, infected with DENV-
2 (Fig. 5b).
Detection of DENV-2 viral genome by RT-PCR
amplification of the NS1 gene sequence
One DNA fragment of 1.1 kb, corresponding to the NS1
gene sequence, was detected in extracts of cells inoculated
with mouse sera collected at the 2nd and the 11th days p.i.
No amplification was observed in control samples cultivated
with non-inoculated mouse sera (Fig. 6). These results
confirmed the presence of DENV-2 in serum samples of
infected mice and indicated that such virus is still able to
infect other cells.
Detection of the period of viremia in serum of BALB/c mice
infected with DENV-2 and inoculated in C6/36 cells (flow
cytometry)
In an attempt to quantify the degree of infection in the
present mouse model, flow cytometry techniques were
applied. A DENV-2 hyperimmune mouse ascitic fluid was
used for the quantification of the virus in the cultures treated
with sera of infected animals. The serum was purchased in
three different time periods after infection (3, 7, and 14
Fig. 3. Detection of DENV-2 antigens in liver of infected mice. (a) Negative control obtained with liver of a non-infected mouse (scale bar = 10 Am); (b) liver of
an infected mouse at the 2nd day p.i., incubated only with anti-human IgG-horseradish peroxidase conjugate, central vein (scale bar = 10 Am); (c–e) liver of an
infected mouse at the 2nd day p.i., incubated with anti-DENV-2 antibodies and anti-human IgG-horseradish peroxidase conjugate. Note the positive reaction in
hepatocytes in focal midzonal (c) and portal space (e) areas (asterisk) (scale bar = 5 Am), and in endothelium capillar (d) (scale bar = 1 Am), biliar duct (BD); (f
and g) liver of an infected mouse at the 13th day p.i., incubated only with the secondary antibody (f) or with primary and secondary antibodies (g) (scale bars =
10 Am). Note the positive reaction in several hepatocytes (asterisk).
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the three different time periods illustrating the clear reaction
of this antibody. Anti-DENV-2 was significantly positive in
cells incubated with serum collected 7 and 14 days after
infection, where a clear shift to the right side of the graph
was observed. The peak of viremia was detected using the
flow cytometer, revealing a ten-fold increase in the
percentage of positive cells for the anti-DENV-2 antibodies
7 days after infection, followed by a subsequent decline of
viremia at day 14th p.i. (Figs. 7a and b). A considerable
individual variation, however, was determined. Six out of
the 8 animals studied were positive to anti-DENV-2 (Figs.
7b and c). Four positive animals achieved the peak of
viremia at day the 7th day p.i., whereas two animals
behaved differently, one reaching its highest level ofinfection at the 14th day p.i. and the other at the 3rd day
p.i. (Figs. 7b and c).Discussion
Dengue is an intriguing disease and the mechanisms
involved in the pathogenesis of DHF/DSS are yet poorly
understood. In an attempt to understand the disease and/or
to test new drugs or vaccines, several studies suggested the
use of murine models (Atrasheuskaya et al., 2003; Huang et
al., 2000a, 2000b; Shresta et al., 2004), although none of
them reproduce the exactly symptoms observed in humans.
In the present report, we evaluated the use of BALB/c
as an experimental mouse model for DENV-2 infection. A
Fig. 4. This serum levels of alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) in mice experimentally infected with DENV-2, at
the 2nd, 3rd, 7th, and 14th days p.i.
M.V. Paes et al. / Virology 338 (2005) 236–246 241DENV-2 isolated from a serum sample obtained from one
patient, followed by cultivation in mosquito cells, was
directly inoculated in mice by the intraperitoneal route.
Animals did not present clinical signs of the infection,
significant hepatic alterations were observed. Histopatho-
logical analysis revealed focal injury in lobular parenchyma
in hepatocytes. These results correlate to what is observed in
humans, in which liver seems to be one target organ. The
biology and clinical aspects of hepatitis is a well-known
feature of human dengue infection (Innis, 1995; Rosen et
al., 1989), although DENV can lead to a mild degree of
hepatic involvement. However, it has been reported in
recent years a severe involvement of the liver, including
cases of fulminant hepatitis with high mortality (Lum et al.,
1993).
The hepatic injury observed in the present mouse model
began 2 days p.i., and at the 3rd day p.i. hepatocytes
presented diffuse steatosis in midzonal areas. Necrosis of
hepatocytes and a strong flux of edema was observed at 7
days p.i. The descriptions of liver histopathology in humans
infected with DENV is yet scarce. The study of a dengue
fatal case in human also showed diffuse hepatitis with
midzonal necrosis and steatosis recruitment of inflammatory
cells into hepatic parenchyma (Huerre et al., 2001). The data
reported in this study correlated with our results. The
observed hepatic injury was similar to that of early stages ofyellow fever infection. An increase of plasma was reported
when infection occurred through the intraperitoneal route.
Simultaneously an increase in the transaminase levels, fatty
changes in hepatocytes, Kupffer cell hyperplasia, and
centrilobular and midzonal necrosis was observed (Innis,
1995; Kuo et al., 1992). The inflammatory infiltrate
presented monocytes and lymphocytes in sinusoids of focal
areas of the portal space. In accordance to this observations,
in our model, mice infected with DENV-2 also presented
numerous hyperplastic Kupffer and monocytes cells into
sinusoids capillar and portal space, respectively. Some
reports have shown that endothelial and Kupffer cells were
susceptible for DENV replication (Hall et al., 1991; Innis,
1995) suffering, therefore, viral cytopathic effects, which
may explain the hyperplasia observed. In fact, in the present
work, viral antigens were detected in capillar endothelium
of the central lobular vein confirming its susceptibility to
virus replication, as well as in several hepatocytes. How-
ever, such antigens were not verified in Kupffer cells. In
humans, antigens of DENV-2 have been detected in liver
tissue, either in Kupffer’s cells or in hepatocytes, spleen,
lymph nodes, pulmonary alveolae, blood mononuclear cells,
peripheral B cells, and thymic cortex (Couvelard et al.,
1999; Hall et al., 1991; Huerre et al., 2001; Innis, 1995; Kuo
et al., 1992; Monath, 1986; Nguyen et al., 1997; Rosen et
al., 1999; Scott et al., 1980; Waterman et al., 1985). Further
studies will be necessary in order to analyze or evaluate the
extension of injury in other organs in mice, with the
presence of viral antigens.
Apoptosis is a major feature of viral hepatitis (Galle et
al., 1995) and also participates of the DENV pathological
spectrum. In our work we could note the presence of
apoptotic cells, mainly at the sinusoidal space, in later stage
of infection, at the 17th day p.i. This apoptosis is probably
related to focal rarefaction of sinusoidal cells and sinusoidal
endothelial. In vitro, various cell lines susceptible for
DENV, such as HepG2 and a mouse neuroblastoma cell
line (Neuro2a), exhibited apoptotic cell death when infected
with DENV (Despre`s et al., 1996; Marianneau et al., 1997).
In humans, apoptosis could also occur in endothelial and
Kupffer cells, therefore leading to the focal sinusoidal
denudation demonstrated herein. Probably the sinusoidal
denudation seen in DENV-2 infection may cause the
microvascular barrier derangement and may be pivotal in
the development of parenchymal damage, contributing to
the microvascular disruption caused by cytokines secreted
by activated cells (Dhawan et al., 1990; Khanna et al.,
1990).
The degree of hepatocytic viral injury induced in DENV
infection could also be observed in the transient liver
dysfunction depicted by enzyme levels. Serum levels of the
alanine aminotransferase (ALT) and aspartate aminotrans-
ferase (AST) can be significantly higher in humans infected
with any of the DENV serotypes. In general, DF is usually
associated with mild to moderate elevations of such
enzymes, while in patients with DHF/DSS ALT and AST
Fig. 5. Electron microscopy of C6/36 cells incubated with sera from DENV-2-infected mice. (a) Negative control of C6/36 cell (scale bar = 1 Am); (b) positive
control of C6/36 cell infected with DENV-2. Note the virus particles (arrow) (scale bar = 0.2 Am); (c and d) C6/36 culture cells inoculated with sera from mice
collected at the 2nd (c) and 11th days p.i. (d). Note the virus particles inside vesicles and vacuoles (arrows) (scale bar = 0.5 Am).
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al., 2004). Peak levels of the transaminases normally
occurred at the 7th day p.i. and decreased in the following
2 weeks. Similar results were observed in the experimental
mouse model here presented, in which levels of both hepatic
transaminases (ALT and AST) increased in most of the
tested serum samples, with peak levels at the 7th day p.i.
Moreover, AST levels in mice were higher than ALT, which
is also verified in humans (Nguyen et al., 1997).
Another parameter for evaluation of DENV infection is
the viremia, which correlates to transaminase levels and
other hepatic damage. In most experimental mouse models,
viremia could not be characterized, probably due to the fact
that circulating DENV is found in a very low level in such
animals, which stands below the sensibility assays for
normal virus titrage and/or isolation (Bhamarapravati and
Halstead, 1964; Boonpucknavig et al., 1981; Nath et al.,
1983; Shresta et al., 2004). In order to amplify the amount
of DENV-2 particles obtained from mouse sera, weinoculated C6/36 cells with serum samples collected in
different time points during the animal infection. Viral
particles could be detected inside those cells by ultra-
structure analysis and its presence was confirmed by PCR
assays. Such results indicated that in fact DENV-2 particles
were circulating in blood samples of infected mice and that
such virus maintains its capacity to replicate in different
cells.
In an attempt to detect the period of viremia in these
animals, C6/36 cells were incubated with mouse serum
samples purchased in different times and analyzed by flow
cytometry. Peak of viremia was observed at the 7th day p.i.
in most animals followed by a subsequent decline at the
14th day p.i. In humans, the peak of viremia is also verified
around the 7th day p.i. with a decrease after 1 week (Kuo et
al., 1992; Mohan et al., 2000). Huang et al. (2000a, 2000b)
also detected viremia in blood samples of A/J mice by RT-
PCR but not in BALB/c mice. However, virus could only be
detected 2 days after inoculation by the intravenous route
Fig. 6. The DENV-2 NS1 gene amplified by PCR and electrophoresed in
1% agarose gel stained with ethidium bromide. Serum samples collected
from mice infected with DENV-2 were added to C6/36 cells and PCR
reactions were performed using cDNAs made from extracts of such cells.
Lanes: (1) standard marker of k DNA digested with HindIII; (2) extract of
cells cultivated with mouse sera collected 2 days following virus infection;
(3) extract of cells cultivated with mouse sera collected 11 days following
virus infection; (4) negative control with extract of cells cultivated with
non-infected mouse sera; (5) positive control with extract of cells infected
with DENV-2; and (6) standard marker of f 174 DNA digested with
HaeIII.
M.V. Paes et al. / Virology 338 (2005) 236–246 243and it disappeared in the following days. Similar results
were described by Atrasheuskaya et al. (2003), using young
BALB/c mice inoculated with DENV-2 by the intraperito-
neal route, in which viremia was detected by PCR after the
2nd day p.i. These experiments, nevertheless, were con-
ducted with a previous mouse brain adapted. In our work,
assays were performed with a DENV-2 isolated from a
patient serum, cultivated in mosquito cells, and directly
infected in mice by the intraperitoneal route.
In our mouse model we found: hepatic alterations,
including liver histopathological injury with the presence
of viral antigens, elevated levels of transaminases, mainly
at the 7th day p.i., and a correlation between the peak of
viremia, and ALT and AST levels. Our results revealed
the ability of a DENV-2 circulating in a human population
to infect BALB/c mice and are therefore a relevant
physiological approach. Moreover, in conclusion, they
demonstrated that this mouse model is feasible for the
study of DENV disease. Furthermore, studies of exper-
imental drugs or vaccines might be performed using the
BALB/c mice.Material and methods
Virus
DENV-2 was isolated from a patient serum during an
outbreak of the virus in the state of Rio de Janeiro, in 1995
(Nogueira et al., 1995), kindly provided by the FlavivirusesLaboratory of the Department of Virology, Fiocruz, RJ.
Virus had not undergone any passage in mouse brain. It was
propagated in Aedes albopictus mosquito cell line mono-
layers (C6/36), in 10 ml tubes, with L-15 medium (Sigma,
USA) supplemented with 1% non-essential amino acids,
10% tryptose phosphate broth and 10% fetal bovine serum,
and maintained at 28 -C for 15 days.
Animals and experimental protocol
All experiments with mice were conducted in compli-
ance with Ethical Principles in Animal Experimentation
stated in the Brazilian College of Animal Experimentation
and approved by the Institute’s Animal Use Ethical
Committee. Adult male BALB/c mice (age of 2 months),
weighing 25 g, obtained from the mouse colony maintained
in the Department of Virology of the Instituto Oswaldo
Cruz, were submitted to an intraperitoneal inoculation with
DENV-2 (104 TCID50/0.2 ml). For histopathological
analysis and biochemical tests, mice, anesthesiated with
4% chloral hydrate (0.4 ml/25 g of animal), were sacrificed
by total cardiac puncture, while for viremia detections
blood samples were collected several times by partial
cardiac puncture. Control animals consisted of non-infected
or L-15 medium inoculated mice, sacrificed as described
above.
Histological study of liver (light microscopy)
Five DENV-2 inoculated animals were sacrificed at the
2nd, 3rd, 7th, 13th, and 17th days p.i. Liver slices were
fixed in Millonig’s fixative, dehydrated in ethanol, and
paraffin embedded. Sections (5 Am thickness) were stained
with hematoxylin and eosin (HE).
Morphometrical analysis
Hepatocyte, sinusoidal density surface, and sinusoidal
cells numerical density were obtained in HE stained
slides, from animals at the 2nd, 13th, and 17th days p.i.
A hundred and thirty images of liver parenchyma
avoiding portal spaces were obtained in a NIKON Eclipse
104 light microscope (40 objective camera) and
digitalized by a NIKON Coolpix 990 digital camera.
From each images, diameters of 20 hepatocytes and 10
sinusoidal spaces, as well as sinusoidal cells counting,
were achieved using a public software Scion (ScionCorp,
USA). Data were submitted to statistical analysis using t
test or Mann–Whitney rank sum test considering signifi-
cance at P < 0.05.
Immunoperoxidase technique for the detection of viral
antigen in mice liver
Paraffin-embedded sections of the liver of infected and
control animals were deparaffinized with three washes in
Fig. 7. FACs analysis of C6/36 cells inoculated with sera collected from DENV-2-infected mice at different time points. (a) Original FACs histograms showing
the time-dependent positivity for the anti-DENV-2 antibody in C6/36 cells treated with sera of one infected animal. Anti-DENV-2 = gray color/histogram, 2nd
antibody = transparent overlaid histogram. Percentage of dengue virus and time of the analysis are shown at the right top of each histogram. (b) Graph showing
the kinetic of infection for all animals studied as percentage of anti-DENV-2-positive cells. Each line represents one animal and each point represents the day of
analysis. Day 1 of infection = . (c) Table containing the values for anti-DENV-2-positive cells for all infected animals in all studied days. Asterisk/bold*
letters showing that in the majority of the animals studied the infection was detected using this experimental model (nv = no value).
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followed by a final wash in PBS. For detection of DENV
antigens, samples of liver from 2 and 13 days p.i. were
incubated over night at 4 -C with an anti-DENV-2 serum
raised in monkey (gently provided by Dr. R. Galler,
Laboratory of Molecular Biology of Flavivirus, Department
of Biochemistry and Molecular Biology, Fiocruz, RJ). After
washing with Tris–HCl (0.05 M pH 7.6), the sections were
further incubated with rabbit anti-human IgG-horseradish
peroxidase conjugate (Sigma) for 30 min at 37 -C. Theslices were revelated with DAB (Sigma) and were counter-
stained with Mayer’s hematoxylin. Controls were stained
with the secondary antibody only.
Biochemical analysis of serum hepatic enzyme
Five infected mice were bleed at the 2nd, 3rd, 7th, until
the 14th days p.i. and serum samples were obtained after
centrifugation at 400 rpm for 5 min and stored at 70 -C.
Levels of alanine aminotransferase (ALT) and aspartate
M.V. Paes et al. / Virology 338 (2005) 236–246 245aminotransferase (AST) were detected by the UVoptimized
(IFCC) method (Karmen, 1955), using commercial kits
(Clm, Brazil).
Statistical analysis
Experimental results on biochemical tests were ana-
lyzed for their statistical significance by t Student and
Kruskal–Wallis test P = 0.051.
Detection by transmission electron microscopy of DENV-2
in C6/36 cell line inoculated with sera from infected BALB/c
mice
Serum samples (100 Al) collected from DENV-2-infected
mice at the 2nd and 11th days p.i. were added to monolayers
of C6/36 cells, grown as described above. Cells were daily
observed for viral cytopathic effects for 15 days. Positive
and negative controls consisted of DENV-2 (102 TCID50/
0.1 ml) infected and non-infected C6/36 monolayers, res-
pectively. Cells were fixed in 1% buffered glutaraldehyde,
dehydrated and embedded in epoxy resin for electron
microscopy observations. Ultra-thin sections of 50–70 nm
thickness were obtained using a diamond knife, double
stained with uranyl acetate and lead citrate, and observed in
a Zeiss EM-900 transmission electron microscope.
Detection of the NS1 DENV-2 gene by PCR amplification in
C6/36 cell line inoculated with sera from infected BALB/c
mice
C6/36 cells were used in order to increase virus titer. The
cells were incubated with mice sera collected at the 2nd and
11th days p.i., as described above, and were used for the
detection of the DENV-2 non-structural protein 1 (NS1).
PCR reactions were performed using cDNAs made from
extracts of such cells, and total RNAs were then extracted
with Trizol (Invitrogen, USA), according to the manufacturer
protocol. The RNAwas used as template for the synthesis of
a cDNA, carried out with the oligonucleotide antisense
primer 5V-CAT AAG CTT ACA GAG GTT CCC CCA TG-
3V, which hybridize between nucleotides 1422 and 1438 in
the NS3 gene. The cDNAwas then used for amplification of
the NS1 gene sequence by Nested PCR. The first PCR
reaction was made with two oligonucleotide primers (sense
5V-G GGG GATATC ATG CTG TCT GTG TCA CTA G-3V
and antisense 5V-G GGG CTC GAG TTA CCC TGT GAT
CAA TG-3V), which anneals between nucleotides 1425 and
1441 and between nucleotides 125 and 141 in the E and
NS2A protein genes, respectively. The oligonucleotide
primers sense 5V-GGG GGA TAT CGA TAG TGG TTG
CGT TG-3V and antisense 5V-GGG GCT CGA GTT AGG
CTG TGA CCA AG-3Vwere then used for the amplification
of the NS1 gene sequence in the second PCR reaction was.
The two PCR reactions were programmed as follows: 94 -C
for 2 min, 40 cycles of 92 -C for 1 min, 55 -C for 1 min,72 -C for 2 min, and an extension step at 72 -C for 5 min at
the end of the cycle. The amplified products were electro-
phoresed on a 1% agarose gel, stained with ethidium
bromide, and photographed with Polaroid film.
Viremia detection by flow cytometry
Eight BALB/c mice were inoculated with DENV-2 as
described above and serum samples of each animal were
collected at the 3rd, 7th, and 14th days post-infection and
stored at 70 -C. C6/36 cells were incubated with the serum
and maintained for 10 days at 28 -C. Infected and non-
infected cells were analyzed by a FACScalibur (Becton
Dickinson). Performance control of the flow cytometer was
accomplished on a regular basis using Calibrite Bead
(Becton Dickinson). All analyses were performed with
intracellular labeling techniques using a PBS/Saponin
solution (0,05%) with preceding cell fixation (fixing
reagents Paraformaldehyde 1%). Primary antibody used
was a DENV-2 hyperimmune mouse ascitic fluid (ATCC,
USA) and the second antibody was a fluorescein-conjugated
goat anti-mouse IgG (Southern Biotechnology, USA). The
standard incubation time with the first antibody was 1 h
at 4 -C and samples underwent a supplementary 30-min
incubation step with the second antibody.Acknowledgments
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